AHI1 gene expression levels and BCR-ABL1 T315I mutations in chronic myeloid leukemia patients

By Balci Tugce Bulakbasi   Sahin Feride Iffet   Karakus Sema   Ozdogu Hakan  

Hematology, Vol. 16, Iss. 6, 2011-11 ,pp. : 357-360

Maney Publishing

Access to resources Recommend Favorite

Detection of BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia on imatinib

By Chahardouli Bahram   Zaker Farhad   Mousavi Seied Asadollah   Saffari Zeinab   Nadali Fatemeh   Ostadali Mohammadreza   Ghadimi Habibeh   Alimoghaddam Kamran   Ghavamzade Ardeshir   Rostami Shahrbano  

Hematology, Vol. 18, Iss. 6, 2013-11 ,pp. : 327-332

Maney Publishing

Access to resources Recommend Favorite

Targeting the Kinase Activity of the BCR-ABL Fusion Protein in Patients with Chronic Myeloid Leukemia

By  

Current Molecular Medicine, Vol. 5, Iss. 7, 2005-11 ,pp. : 615-623

Bentham Science Publishers

Access to resources Recommend Favorite

Reconsideration of BCR‐ABL protein flow cytometric immunobead assay: how potent to diagnose and monitor chronic myeloid leukemia?

By  

International Journal Of Laboratory Hematology, Vol. 37, Iss. 5, 2015-10 ,pp. : 723-728

John Wiley & Sons Inc

Access to resources Recommend Favorite

p210 BCR/ABL1 as a secondary change in a patient with acute myelomonocytic leukemia (M4Eo) with inv(16)

By Dai Hai-ping  

International Journal of Hematology, Vol. 96, Iss. 6, 2012-12 ,pp. : 814-817

Springer Publishing Company

Access to resources Recommend Favorite